| ||
| ||
| Stocks To Watch On Tuesday: Hewlett-Packard, SAP, GlaxoSmithKline, Diageo Daily Markets ... to Alliance Capital Group (Eindhovens Dagblad) Roche – Co. obtained a global license from Genzyme to develop a test for lung cancer cell mutations. ... See all stories on this topic » |
| ||
| GRHU, CRWE, BTUI, SNTA, APAC Stock Update DoubleInStocks.com ... By The News Desk Its research and development programs include STA-9090, an Hsp90 inhibitor that is in Phase II stage for non-small cell lung cancer and gastrointestinal stromal tumors, as well as in Phase I for hematologic cancers and solid tumors; ... Sacramento Ca Double In Stocks - http://sacramento.california.doubleinstocks.com/ | ||
| FACE, NVSL, SSE, ARIA, EEGI, PTSH Stock Market Report from ... By The News Desk The company's lead cancer product candidate, ridaforolimus is being studied in multiple clinical trials in patients with various types of cancers, including sarcomas, breast cancer, prostate cancer, non-small cell lung cancer, ... Los Angeles Ca - http://losangeles.california.drstockpick.com/ |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment